Telehealth-delivered opioid agonist therapy for the treatment of adults with opioid use disorder review of clinical effectiveness, cost-effectiveness, and guidelines
This Rapid Response report aims to review the effectiveness of the use of telehealth-delivered opioid agonist therapy (OAT) compared to standard OAT. Cost-effectiveness and evidence-based guidelines regarding the use of telehealth-delivered OAT for the treatment of opioid use disorders will also be...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
CADTH
October 5, 2018, 2018
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This Rapid Response report aims to review the effectiveness of the use of telehealth-delivered opioid agonist therapy (OAT) compared to standard OAT. Cost-effectiveness and evidence-based guidelines regarding the use of telehealth-delivered OAT for the treatment of opioid use disorders will also be examined |
|---|---|
| Physical Description: | 1 PDF file (13 pages) illustrations |